Research and innovation around Clostridium difficile infection (CDI) has been a
multidisciplinary endeavor since discovery of the organism in 1978. The field of …

Background Immunocompromised patients are particularly vulnerable to Clostridioides
difficile infection (CDI), hospitalizations and recurrences. Studies have shown that fecal …

Introduction Fecal microbiota transfer (FMT) is highly effective in the treatment and
prevention of recurrent Clostridioides difficile infection (rCDI) with cure rates of about 80 …

Background Fecal microbiota transfer (FMT) is increasingly being used in Germany, as in
other countries, for the treatment of recurrent Clostridioides difficile infection (rCDI). FMT is …

Reduction in diversity of the intestinal microbiome (dysbiosis) is being identified in many
disease states, and studies are showing important biologic contributions of microbiome to …

Introduction Recently the role of gut microbial dysbiosis in many ocular disorders, including
but not limited to uveitis, age-related macular degeneration (AMD), diabetic retinopathy …

Gastrointestinal (GI) symptoms represented by constipation were significant non-motor
symptoms of Parkinson's disease (PD) and were considered early manifestations and …

Introduction: Fecal microbiota transplantation (FMT) is a procedure involving transfer of stool
from a healthy donor into the intestinal tract of a diseased recipient to restore intestinal …

Oral vancomycin and metronidazole, though they are the therapeutic choice for
Clostridioides difficile infections (CDIs), also markedly disturb microbiota, leading to a …

Abstract The Antibacterial Resistance Leadership Group (ARLG) Mentoring Program was
established to develop and prepare the next generation of clinician-scientists for a career in …